Long-term outcomes of laparoscopic Roux-en-Y gastric bypass vs laparoscopic sleeve gastrectomy for obesity

JAMA Surgery

2025-02-19

(Press-News.org) About The Study: After more than 10 years of follow-up in the Swiss Multicenter Bypass or Sleeve Study randomized clinical trial, Roux-en-Y gastric bypass demonstrated superiority over sleeve gastrectomy for patient excess body mass index loss.

Corresponding Author: To contact the corresponding author, Ralph Peterli, MD, email ralph.peterli@clarunis.ch.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamasurg.2024.7052)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2024.7052?guestAccessKey=6be4f57c-db3f-4132-bbdf-74a40db4aeb7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021925

END

ELSE PRESS RELEASES FROM THIS DATE:

Advances in AI can help prepare the world for the next pandemic, global group of scientists find

2025-02-19

In the next five years, integrating AI into country response systems could save more lives by anticipating the location and trajectory of disease outbreaks. Global group of researchers call for better collaboration between academia, government and industry, to ensure safety, accountability and ethics in the use of AI in infectious disease research. A study published in Nature today outlines for the first time how advances in AI can accelerate breakthroughs in infectious disease research and outbreak response. The study – which ...

Emergency clinicians increase prescriptions of buprenorphine, effectively help patients get started on the path to recovery

2025-02-19

In the face of the alarming number of opioid-related deaths in the U.S., there have been national efforts to increase emergency clinician prescribing of buprenorphine, a medication used to treat opioid use disorder. In a new study published in JAMA, UCLA Health researchers report on the extent and success rate of such efforts in California. Opioid-related emergency department (ED) visits, hospitalizations, and deaths have increased markedly since 1999, and the growing number of cases was declared a public health emergency in 2024. Combined ...

New sensor can take any gas and tell you what’s in it

2025-02-19

Expert sommeliers can take a whiff of a glass of wine and tell you a lot about what’s in your pinot noir or cabernet sauvignon. A team of physicists at CU Boulder and the National Institute of Standards and Technology (NIST) have achieved a similar feat of sensing, only for a much wider range of substances. The group has developed a new laser-based device that can take any sample of gas and identify a huge variety of the molecules within it. It is sensitive enough to detect those molecules at minute concentrations all the way down to parts per trillion. ...

How the brain balances risk and reward in making decisions

2025-02-19

At a glance: Study in mice offers insights into the brain circuitry underlying certain types of reward-based choices. Researchers identified distinct groups of brain cells activated when animals anticipate a reward to be above average or below average for a choice. The findings enhance understanding of human decision-making and how the brain balances risk and reward. Every day, our brain makes thousands of decisions, big and small. Any of these decisions — from the least consequential such as picking ...

Jumbled proteins paint a bold target on the backs of brain tumors

2025-02-19

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue. Now, researchers at UC San Francisco have found that some cancers, like deadly brain cancer (glioma), make unique, jumbled proteins that make them stand out. These newly recognized cancer-specific proteins, or antigens, could speed the development of potent immunotherapies that recognize and attack hard-to-treat tumors. The study, which was supported through grants from the National Institutes of Health, appears in Nature on ...

Liver injury in immune Stevens-Johnson Syndrome and toxic epidermal necrolysis: Five new classification types

2025-02-19

Introduction First identified by Stevens and Johnson in 1922, SJS and TEN are now recognized as disorders with a continuum of severity, from milder forms (SJS) to the most severe (TEN). SJS/TEN is associated with multiple etiological factors, most notably drug-induced liver injury (DILI), making the identification of the responsible agent crucial for patient management. However, previous studies have lacked uniformity in diagnostic approaches, limiting the ability to draw clear conclusions about causality. Epidemiology The incidence of SJS/TEN varies across regions, with notable differences between studies. For instance, ...

MSU study: Socioeconomic factors, unpredictability complicate diagnosis of episodic disabilities, like epilepsy

2025-02-19

Any patient suffering from new or worsening medical symptoms hopes for a relatively quick and accurate diagnosis. However, for many people with episodic disabilities — periodic or intermittent conditions like migraines, lupus, Crohn’s disease and epilepsy, in which the presence and severity of symptoms fluctuate — a swift diagnosis is not guaranteed. New research from Michigan State University focuses on diagnostic delays experienced by people with one such condition: epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people in the United States and 50 million worldwide. “Epilepsy ...

Revolutionizing tropical disease treatment: The future of conjugating nanomaterials with drugs

2025-02-19

Introduction Neglected Tropical Diseases (NTDs) remain a significant health burden in tropical and subtropical regions, with limited treatment options and diagnostic capabilities. These diseases are often neglected in research and policy, yet they contribute to high mortality and morbidity worldwide. Nanotechnology, particularly the conjugation of nanomaterials with drugs, presents an innovative approach to improving both the diagnosis and treatment of these diseases. Nanomaterials have unique properties that allow for enhanced drug delivery, ...

Improving quality of life and end-of-life care: Standardizing goals of care notes in EHRs

2025-02-19

INDIANAPOLIS – It is important that a healthcare team is aware of and understands a patient’s goals of care, both medical and personal. But that information, if documented, typically is not placed in a standardized location and is difficult to find within a patient’s voluminous electronic health record (EHR). A new study by researchers from Regenstrief Institute, the Indiana University School of Medicine and Indiana University Health presents the standardized goals of care note they developed, deployed and evaluated as a quality improvement initiative at ...

Taking vitamin E during pregnancy may decrease peanut allergy in children

2025-02-19

New research found that supplementing maternal diet with α-tocopherol, a form of vitamin E, can reduce the development of food allergy and anaphylaxis in newborn mice. The prevalence of food allergy in children increased 50% from 2007 to 2021 in the United States (US), with the incidence of peanut allergy tripling in that time. This new study, published in The Journal of Immunology, shows the potential for α-tocopherol in prenatal vitamins during pregnancy and lactation to address this alarming increase and reduce development of food allergy early in life. The study found that ...

LAST 30 PRESS RELEASES:

Could we use eye drops instead of reading glasses as we age?

Patients who had cataracts removed or their eyesight corrected with a new type of lens have good vision over all distances without spectacles

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows